We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Hypersegmented Neutrophils Associated with Reduced Lung Function

By LabMedica International staff writers
Posted on 19 Feb 2019
Neutrophils are phagocytic innate immune cells, which patrol the blood vessels and become activated in response to inflammatory triggers. More...
Activation results in neutrophil migration to the site of infection, where pathogens can be eliminated by phagocytosis or NETosis.

Inflammation characterized by airway neutrophilia is reported in many cases of chronic obstructive airway disease. This includes 20% to 30% cases of asthma, more than 40% cases of chronic obstructive pulmonary disease (COPD), and 70% cases of non-cystic fibrosis (CF) bronchiectasis.

Scientists at the University of Newcastle (Callaghan, Australia) and their associates recruited adults who were undergoing bronchoscopy either for medical purposes or were undergoing a surgical procedure that involved endotracheal intubation and had spirometry results. Participants included 78 adults with obstructive airway disease comprised of 39 with stable asthma, 20 with COPD and 19 diagnosed as bronchiectasis and 20 healthy controls.

Spirometry was performed using an Easy One Spirometer. Flexible bronchoscopy was performed and a fraction of the bronchial lavage (BL) was sent for microbial detection while the rest was processed. The BL was centrifuged and the cell pellet was resuspended in phosphate buffered saline to the concentration of 1×106/mL and cellular cytospins were prepared. The cytospins were stained with May-Grünwald Giemsa and a differential cell count of 400 non-squamous cells was performed.

The team reported that the numbers of hypersegmented neutrophils were significantly elevated in participants with airway disease compared with healthy controls. Both the number and the proportion of hypersegmented neutrophils were highest in COPD participants (median (Q1–Q3) of 1,073.6 (258.8–2,742) × 102/mL and 24.5 (14.0–46.5) %, respectively). An increased proportion of hypersegmented neutrophils in airway disease participants was significantly associated with lower forced expiratory volume in 1 s/forced vital capacity percent. In participants with COPD, the proportion of hypersegmented neutrophils was positively associated with proportion of eosinophils and negatively associated with cell viability.

The authors concluded that the presence of three morphologically different subsets of neutrophils in the airways of healthy and obstructive airway disease participants, that is, asthma, COPD and bronchiectasis. The increased proportion of hypersegmented neutrophils in the airways of obstructive airway disease participants was associated with reduced lung function of these participants. The proportion of hypersegmented neutrophils was highest in COPD participants in comparison to all other groups. The study was published on January 28, 2019, in the journal BMJ OPEN.

Related Links:
University of Newcastle


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Electrolyte Analyzer
BKE-B
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
image Credit: iStock

Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

Outcomes after resection for lung squamous cell carcinoma (SqCC) vary substantially, and the uneven benefit of adjuvant chemotherapy complicates postsurgical treatment decisions. Pathologic markers that... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.